awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47715888-96F2BBB6-962E-44A8-8312-61E793A38CEA
Q47715888-96F2BBB6-962E-44A8-8312-61E793A38CEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47715888-96F2BBB6-962E-44A8-8312-61E793A38CEA
Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.
P2860
Q47715888-96F2BBB6-962E-44A8-8312-61E793A38CEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47715888-96F2BBB6-962E-44A8-8312-61E793A38CEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93eb02ae346b76c81bd2776b92a72c399081dcd5
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.